These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 21469392)
1. A stronger role for science. Nat Rev Drug Discov; 2011 Mar; 10(3):159. PubMed ID: 21469392 [TBL] [Abstract][Full Text] [Related]
2. Fix the antibiotics pipeline. Cooper MA; Shlaes D Nature; 2011 Apr; 472(7341):32. PubMed ID: 21475175 [No Abstract] [Full Text] [Related]
3. Learning lessons from Pfizer's $800 million failure. Nat Rev Drug Discov; 2011 Mar; 10(3):163-4. PubMed ID: 21358723 [No Abstract] [Full Text] [Related]
4. Discontinued drugs in 2010: oncology drugs. Williams R Expert Opin Investig Drugs; 2011 Nov; 20(11):1479-96. PubMed ID: 21955127 [TBL] [Abstract][Full Text] [Related]
5. European lead factory opens for business. Mullard A Nat Rev Drug Discov; 2013 Mar; 12(3):173-5. PubMed ID: 23449292 [No Abstract] [Full Text] [Related]
10. The critical impact of time discounting on economic incentives to overcome the antibiotic market failure. Spellberg B; Sharma P; Rex JH Nat Rev Drug Discov; 2012 Feb; 11(2):168. PubMed ID: 22293569 [No Abstract] [Full Text] [Related]
11. Biopharma deal-making in 2016. Micklus A; Muntner S Nat Rev Drug Discov; 2017 Mar; 16(3):161-162. PubMed ID: 28209988 [No Abstract] [Full Text] [Related]
12. Drug development: A combined effort. Maxmen A Nature; 2013 Oct; 502(7470):S4-6. PubMed ID: 24108079 [No Abstract] [Full Text] [Related]
13. [Open innovation and licensing in the pharmaceutical industry]. Yamasaki M Nihon Yakurigaku Zasshi; 2013 Jul; 142(1):28-31. PubMed ID: 23842225 [No Abstract] [Full Text] [Related]
14. Ask the experts: future of the pharmaceutical industry. Interview by Future Medicinal Chemistry. Cottens S; Eaton M; Fuhr J; Geary S; Johnson DS; Li G; Raveglia L; Robertson GM; Westwell A Future Med Chem; 2011 Nov; 3(15):1863-72. PubMed ID: 22023030 [TBL] [Abstract][Full Text] [Related]
15. Michael Rosenblatt. Nat Rev Drug Discov; 2016 Sep; 15(10):672. PubMed ID: 27681789 [No Abstract] [Full Text] [Related]
16. Open innovation: share or die.. Talaga P Drug Discov Today; 2009 Nov; 14(21-22):1003-5. PubMed ID: 19778629 [No Abstract] [Full Text] [Related]
18. The current state of drug discovery and what it might take to improve drug discovery outcomes and approval successes. Turner MJ Drug Discov Today; 2015 Aug; 20(8):917-9. PubMed ID: 26100736 [No Abstract] [Full Text] [Related]
19. What are the economic barriers of antibiotic R&D and how can we overcome them? Renwick M; Mossialos E Expert Opin Drug Discov; 2018 Oct; 13(10):889-892. PubMed ID: 30175625 [No Abstract] [Full Text] [Related]
20. Overcoming the obstacles in the pharma/biotech industry: 2008 update. Graul AI; Revel L; Rosa E; Cruces E Drug News Perspect; 2009; 22(1):39-51. PubMed ID: 19209298 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]